A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit. Illustration:......
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on......
'Just put a patch on your arm and the vaccine can be absorbed by the body.' IMAGE: Administering vaccines through the oral and nasal route are also likely to gain popularity over the traditional......
Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its COVID-19 vaccine ZyCoV-D to the central government. Photograph: Kind courtesy Zydus Cadila The company has initiated the......
There will not be a third wave of Covid of the size and consequence the country witnessed during the second wave unless there is a new variant of coronavirus, top vaccinologist Gagandeep Kang said......
Equity benchmark indices Sensex and Nifty slumped over 1 per cent on Tuesday, weighed down by an across-the-board selloff amid cautious investors approach ahead of the US Fed interest rate......
The Indian equity markets will soon account for over a fifth of a key emerging market (EM) benchmark tracked by funds with assets exceeding $500 billion. Photograph: Thomas White/Reuters This......
Midcap stocks Hero MotoCorp, Zydus Lifesciences, JSW Energy, NHPC, Bharat Heavy Electricals, Bosch, and Samvardhana Motherson are expected to earn upgrades. IMAGE: Kindly note the image has been......
Mutual funds’ largecap investment universe is expected to see seven changes in the upcoming stock reclassification exercise by the Association of Mutual Funds in India (Amfi). Illustration:......
The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......